Mankind Pharma jumped 5.31% to Rs 4,240.75 after the company’s consolidated net profit surged 30.43% to Rs 653.47 crore on a 13.6% rise in revenue to Rs 3,076.51 crore in Q2 FY25, compared to Q2 FY24.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
